EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools PARIS, May 20, 2025 ...

A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather in Paris for this year’s EuroPCR. Intravascular lithotripsy (IVL) has become ...

Johnson & Johnson’s Shockwave Medical strengthened its position in the intravascular lithotripsy (IVL) market. The New Brunswick, NJ-based company said earlier this week that it was launching the ...

SAN FRANCISCO, CA—The use of cutting and noncompliant balloons for lesion preparation appears to provide results similar to those achieved with Shockwave intravascular lithotripsy (IVL; Shockwave ...

Johnson & Johnson shocked the medtech industry early last year when it announced it would acquire Shockwave Medical, a specialist in the intravascular lithotripsy (IVL) market. Shockwave had a huge ...

Balloon lithotripsy better prepared severely calcified lesions for stenting compared with conventional techniques, based on results of intravascular imaging in the small, 200-person BALI trial. Among ...

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions Technology has received U.S. FDA ...